# reload+after+2024-01-22 10:45:32.798054
address1§50 rue de Dijon
city§Daix
zip§21121
country§France
phone§33 3 80 44 75 00
website§https://www.inventivapharma.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.
fullTimeEmployees§117
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Frederic  Cren', 'age': 57, 'title': 'Co-Founder, CEO & Chairman', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 552690, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Pierre  Broqua Ph.D.', 'age': 61, 'title': 'Co-Founder, Chief Scientific Officer, Deputy CEO & Director', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 414552, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jean  Volatier', 'age': 58, 'title': 'Chief Financial Officer', 'yearBorn': 1965, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Alice  Roudot-Ketelers Pharm.D.', 'title': 'Chief Operating Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Eric  Duranson L.L.M.', 'age': 49, 'title': 'General Counsel', 'yearBorn': 1974, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Nathalie  Harroy', 'age': 56, 'title': 'Head of Human Resources', 'yearBorn': 1967, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Michael  Cooreman', 'age': 65, 'title': 'Chief Medical Officer', 'yearBorn': 1958, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§8
boardRisk§8
compensationRisk§5
shareHolderRightsRisk§9
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.912
priceToSalesTrailing12Months§10.683585
currency§USD
dateShortInterest§1702598400
exchange§NGM
quoteType§EQUITY
shortName§Inventiva S.A. - American Depos
longName§Inventiva S.A.
firstTradeDateEpochUtc§1594387800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§482cc7a0-aa3a-38d9-b65d-b974eb27bb5d
gmtOffSetMilliseconds§-18000000
recommendationKey§none
quickRatio§1.147
grossMargins§0.95768
ebitdaMargins§0.0
trailingPegRatio§None
